Arthroplasty, Replacement, Hip Clinical Trial
Official title:
A Prospective Open-Label Evaluation of the Restoration® Modular System
Verified date | August 2014 |
Source | Stryker Orthopaedics |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.
Status | Completed |
Enrollment | 137 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Candidates for cementless revision of a failed femoral prosthesis. - Patients willing to sign the informed consent. - Patients able to comply with follow-up requirements including post-operative weightbearing restrictions and self-evaluations. - Male and non-pregnant female patients ages 18 to 85 years of age at the time of surgery. Exclusion Criteria: - Patients with ongoing infection. - Patients who are severely immunocompromised. - Patients who are prisoners. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Crystal Clinic | Akron | Ohio |
United States | Orthopedic Associates of Corpus Christi | Corpus Christi | Texas |
United States | Iowa Orthopaedic Center | Des Moines | Iowa |
United States | New West Sports Medicine and Orthopaedic Surgery | Kearney | Nebraska |
United States | Jewish Hospital Center for Advanced Medicine | Louisville | Kentucky |
United States | Beth Israel Medical Center | New York | New York |
United States | Hospital for Joint Diseases | New York | New York |
United States | Orthopaedic Specialty Institute | Orange | California |
United States | Rothman Institute | Philadelphia | Pennsylvania |
United States | Providence Portland Medical Center | Portland | Oregon |
United States | Providence Orthopaedic Specialities | Spokane | Washington |
United States | Scott and White Hospital | Temple | Texas |
United States | Kansas Joint and Spine Institute | Wichita | Kansas |
Lead Sponsor | Collaborator |
---|---|
Stryker Orthopaedics |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stem Survivorship (%) | Failure is defined by stem revision for any cause. | 5 years | Yes |
Primary | Femoral Stem Fracture | 5 years | Yes | |
Secondary | Radiographic Stability | Absence of a radiolucent lines = 2mm around the entire stem in AP or ML view. | 5 years | Yes |
Secondary | Harris Hip Score | Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor. 90 - 100 = excellent 80 - 89 = good 70 - 79 = fair 0 - 69 = poor |
pre-op and 5 years | No |
Secondary | SF-36 Health Status Survey: Role - Physical | Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state: The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health This Secondary Outcome Measure is focused on the "Role-Physical" score. |
pre-op, 2 year and 5 year | No |
Secondary | Post-surgery Femoral Crack/Fracture and Subsidence Rate | Post-op to 5 years | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Recruiting |
NCT03746925 -
Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches
|
N/A | |
Completed |
NCT03008967 -
A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark
|
N/A | |
Completed |
NCT00980616 -
Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)
|
Phase 2 | |
Not yet recruiting |
NCT00958945 -
Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements
|
N/A | |
Completed |
NCT04542174 -
PMCF 8 Year Results TRJ®
|
||
Not yet recruiting |
NCT04019925 -
Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis
|
N/A | |
Recruiting |
NCT06102811 -
Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty
|
N/A | |
Recruiting |
NCT03570944 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
|
||
Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
Completed |
NCT03076827 -
Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol
|
N/A | |
Recruiting |
NCT02385383 -
An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
|
N/A | |
Completed |
NCT01444586 -
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
|
N/A | |
Terminated |
NCT02525627 -
A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads
|
N/A | |
Completed |
NCT00808483 -
Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty
|
N/A | |
Terminated |
NCT00958347 -
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
|
N/A | |
Completed |
NCT01422304 -
Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)
|
Phase 3 | |
Completed |
NCT04332055 -
RCT Measuring the Effect of the ERVIN Software
|
N/A | |
Completed |
NCT01257568 -
Rejuvenate Modular Outcomes Study
|
N/A | |
Recruiting |
NCT01031732 -
Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty
|
N/A |